Anti-leukemia activity of human gamma delta T cells

被引：5
|
作者：
Siegers, Gabrielle M. [1 ,2 ]
机构：
[1] Univ Western Ontario, Robarts Res Inst, Imaging Res Labs, London, ON, Canada
[2] Univ Toronto, Princess Margaret Hosp, Cell Therapy Program, Toronto, ON, Canada
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 02期
关键词：
gamma delta T cells; expansion protocol; preclinical investigation; in vivo bioluminescent xenograft model; adoptive cellular immunotherapy; PERIPHERAL-BLOOD; LYMPHOCYTES; LEUKEMIA;
D O I：
10.4161/onci.1.2.18231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two recently published articles from Siegers and colleagues detail both a novel human gamma delta T cell (GDTc) expansion protocol and a bioluminescent xenograft model of Ph+ leukemia, in which GDTc adoptive therapy was tested. Additionally, B-cell chronic lymphocytic leukemia-derived cells were newly identified as targets of preferentially expanded Vdelta1 GDTc.
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [21] Human gamma delta T Cells and Tumor Immunotherapy
    Tanaka, Yoshimasa
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2006, 46 (01) : 11 - 23
  • [22] Eomes and T-Bet Expression Are Required By Mature Primary Human NK Cells for Anti-Leukemia Responses In Vivo
    Wong, Pamela
    Neal, Carly C.
    Chang, Lily
    Wagner, Julia A.
    Berrien-Elliott, Melissa M.
    Cubitt, Celia C.
    Tran, Jennifer
    Russler-Germain, David A.
    Marin, Nancy D.
    Foltz-String, Jennifer A.
    Marsala, Lynne
    Schappe, Timothy
    Fehniger, Todd A.
    BLOOD, 2021, 138
  • [23] Myricetin is a novel inhibitor of human inosine 5′-monophosphate dehydrogenase with anti-leukemia activity
    Pan, Huiling
    Hu, Qian
    Wang, Jingyuan
    Liu, Zehui
    Wu, Dang
    Lu, Weiqiang
    Huang, Jin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (04) : 915 - 922
  • [24] The role and mechanism of AZD5363 anti-leukemia activity in T-cell acute lymphoblastic leukemia
    Luo, Danqing
    Li, Shen
    Guo, Jin
    Yue, Huixuan
    Shi, Lixiao
    Liu, Rong
    Wang, Jianhua
    Shi, Xiaodong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 963
  • [25] In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells
    Yildian Díaz-Rodríguez
    Paulo Cordeiro
    Assila Belounis
    Sabine Herblot
    Michel Duval
    Cancer Immunology, Immunotherapy, 2017, 66 : 1307 - 1320
  • [26] In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells
    Diaz-Rodriguez, Yildian
    Cordeiro, Paulo
    Belounis, Assila
    Herblot, Sabine
    Duval, Michel
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1307 - 1320
  • [27] Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia
    Manman Deng
    Jie Zha
    Zhiwu Jiang
    Xian Jia
    Yuanfei Shi
    Peng Li
    Xiao Lei Chen
    Zhihong Fang
    Zhiqiang Du
    Bing Xu
    Journal of Translational Medicine, 16
  • [28] ANTI-LEUKEMIA ACTIVITY IN OSCILLATORIACEAE - ISOLATION OF DEBROMOAPLYSIATOXIN FROM LYNGBYA
    MYNDERSE, JS
    MOORE, RE
    KASHIWAGI, M
    NORTON, TR
    SCIENCE, 1977, 196 (4289) : 538 - 540
  • [29] Anti-leukemia effect of resveratrol
    Tsan, MF
    White, JE
    Maheshwari, JG
    Chikkappa, G
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 983 - 987
  • [30] Berbamine derivatives: A novel class of compounds for anti-leukemia activity
    Xie, Jinwen
    Ma, Ting
    Gu, Ying
    Zhang, Xuzhao
    Qiu, Xi
    Zhang, Lei
    Xu, Rongzhen
    Yu, Yongping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (08) : 3293 - 3298
12345